GLS-1027

· GeneOne Life Science, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GLS-1027, covering 2025-04-11 to 2025-04-11. Get the full timeline:

Most recent: Clinical Trial Update: GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19) [Phase 2]